These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23875778)

  • 1. Pediatric lipidology.
    Moodie D
    Congenit Heart Dis; 2013; 8(4):271-2. PubMed ID: 23875778
    [No Abstract]   [Full Text] [Related]  

  • 2. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
    Reiner Z
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dislypidemia as a risk factor for cardiovascular disease].
    Anghel L; Ghiuru R; Gavrilescu CM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):977-81. PubMed ID: 21500446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for treating lipids for prevention: risk stratification models with and without imaging.
    Okwuosa TM; Mallikethi-Reddy S; Jones DM
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):295-307. PubMed ID: 24840260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current ways of treating dyslipidemias to prevent atherosclerosis.
    Angelico F; Baratta F; Del Ben M
    Ther Apher Dial; 2013 Apr; 17(2):125-9. PubMed ID: 23551668
    [No Abstract]   [Full Text] [Related]  

  • 6. Associations between aggressive behaviour scores and cardiovascular risk factors in childhood.
    Louise S; Warrington NM; McCaskie PA; Oddy WH; Zubrick SR; Hands B; Mori TA; Briollais L; Silburn S; Palmer LJ; Mattes E; Beilin LJ
    Pediatr Obes; 2012 Aug; 7(4):319-28. PubMed ID: 22511563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid abnormalities and cardiovascular risk in the elderly.
    Milionis HJ; Elisaf MS; Mikhailidis DP
    Curr Med Res Opin; 2008 Mar; 24(3):653-7. PubMed ID: 18218195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting levels and functions of blood lipids in the prevention of CVD.
    Mearns BM
    Nat Rev Cardiol; 2011 Apr; 8(4):179-80. PubMed ID: 21436841
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should advanced lipoprotein testing be used in clinical practice?
    Stein JH; McBride PE
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):640-1. PubMed ID: 17122792
    [No Abstract]   [Full Text] [Related]  

  • 11. Is lipid control necessary in hemodialysis patients?
    Cheung AK
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S95-101. PubMed ID: 19996012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia.
    Haring R; Baumeister SE; Völzke H; Dörr M; Felix SB; Kroemer HK; Nauck M; Wallaschofski H
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):86-96. PubMed ID: 20562628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register.
    Eriksson M; Zethelius B; Eeg-Olofsson K; Nilsson PM; Gudbjörnsdottir S; Cederholm J; Eliasson B
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):97-105. PubMed ID: 21354969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk.
    Sulkes D; Brown BG; Krauss RM; Segrest JP; Sniderman AD; Roberts WC
    Am J Cardiol; 2008 Mar; 101(6):828-42. PubMed ID: 18328849
    [No Abstract]   [Full Text] [Related]  

  • 16. Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?
    Shah PK
    Rev Cardiovasc Med; 2011; 12(2):e55-9. PubMed ID: 21796083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
    Raal FJ
    Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging in haemophilia: getting to the heart of the matter.
    Ragni MV
    Thromb Haemost; 2011 Feb; 105(2):207-8. PubMed ID: 21225103
    [No Abstract]   [Full Text] [Related]  

  • 19. A meta-analysis of the effect of soy protein supplementation on serum lipids.
    Reynolds K; Chin A; Lees KA; Nguyen A; Bujnowski D; He J
    Am J Cardiol; 2006 Sep; 98(5):633-40. PubMed ID: 16923451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme.
    Nery AB; Mesquita ET; Lugon JR; Kang HC; de Miranda VA; de Souza BG; Andrade JA; Rosa ML
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):233-9. PubMed ID: 21450670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.